4726 logo

Mycenax Biotech Inc. Stock Price

TPEX:4726 Community·NT$6.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

4726 Share Price Performance

NT$31.25
-2.50 (-7.41%)
NT$31.25
-2.50 (-7.41%)
Price NT$31.25

4726 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Slightly overvalued with imperfect balance sheet.

2 Risks
0 Rewards

Mycenax Biotech Inc. Key Details

NT$740.2m

Revenue

NT$921.7m

Cost of Revenue

-NT$181.4m

Gross Profit

NT$267.2m

Other Expenses

-NT$448.6m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-2.16
-24.51%
-60.61%
56.9%
View Full Analysis

About 4726

Founded
2001
Employees
n/a
CEO
Pei-Jiun Chen
WebsiteView website
www.mycenax.com

Mycenax Biotech Inc. provides biopharmaceutical services and solutions for drug development and production in Taiwan. The company’s services include program evaluation/confirmation, cell line development and construction, process development technology platforms, drug characterization analysis, establishment of testing methods, and PIC/S GMP drug production. It offers plasmid DNA, antibody-drug conjugates, cell and gene therapy, and exosomes products and services. The company was founded in 2001 and is headquartered in Zhubei, Taiwan.

Recent 4726 News & Updates

Recent updates

No updates